NEW YORK (GenomeWeb) – EKF Diagnostics today announced that it has received a $110 million offer from an undisclosed buyer for its point-of-care diagnostics business.

The firm has received a non-binding preliminary proposal for the business, which excludes its clinical chemistry and molecular diagnostics businesses. The offer is one of the results from a strategic review initiated April 2 by the firm's board of directors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.